Phase 2 Biomarker Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma
Recurrent or Metastatic Esophageal AdenocarcinomaBiomarker-selected CLDN18.2-positive and/or HER2-positive Disease
Beijing Biotech36 enrolled1 locationNCT07622940
Recruiting
Phase 1Phase 2
EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC
Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaBiomarker-positive EGFR/HER2- Expressing HNSCC
Beijing Biotech42 enrolled1 locationNCT07617805
Recruiting
Phase 2
Nitrous Oxide in the Treatment of Acute Suicidal Ideation
Biomarkers / BloodSuicidal IdeationSuicidality+3 more
University of Zurich85 enrolled1 locationNCT06636357
Recruiting
Phase 2
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
Esophageal Squamous Cell CarcinomaImmunotherapyBiomarkers
Fujian Medical University Union Hospital48 enrolled1 locationNCT06510660
Recruiting
Phase 2Phase 3
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
BiomarkersAKI - Acute Kidney InjuryCKD+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran100 enrolled1 locationNCT05713851
Recruiting
Phase 2
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
Neoadjuvant TherapyResectable Lung Non-Small Cell CarcinomaImmunotherapy+1 more
Shandong Cancer Hospital and Institute30 enrolled1 locationNCT06241807